|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1998-12-30
|
|
pubmed:abstractText |
We have investigated the effects of interleukin (IL)-10, IL-4 + granulocyte/macrophage colony-stimulating factor (GM-CSF) and tumour necrosis factor alpha (TNF-alpha) on the phenotype and antigen-presenting capacity of synovial fluid (SF) macrophages from patients with rheumatoid arthritis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0263-7103
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1207-14
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9851271-Adult,
pubmed-meshheading:9851271-Aged,
pubmed-meshheading:9851271-Antigen Presentation,
pubmed-meshheading:9851271-Antigens, CD40,
pubmed-meshheading:9851271-Antigens, CD80,
pubmed-meshheading:9851271-Arthritis, Rheumatoid,
pubmed-meshheading:9851271-Down-Regulation,
pubmed-meshheading:9851271-Female,
pubmed-meshheading:9851271-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:9851271-Humans,
pubmed-meshheading:9851271-Interleukin-10,
pubmed-meshheading:9851271-Macrophages,
pubmed-meshheading:9851271-Male,
pubmed-meshheading:9851271-Middle Aged,
pubmed-meshheading:9851271-Synovial Fluid,
pubmed-meshheading:9851271-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Interleukin-10 inhibits the capacity of synovial macrophages to function as antigen-presenting cells.
|
|
pubmed:affiliation |
Turku Immunology Centre, Department of Medical Microbiology, Turku University, Finland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
